The Cannabis Health Index pdf

UWE BLESCHING is the author of multiple books in the areas of cannabinoid health sciences and mind-body medicine. A former San Francisco paramedic with a lifelong interest in Integrative Medicine, Uwe was inspired to focus his Ph.D. studies on alternative healing and then share his decades of expertise through his writing. Most recently, Uwe has been Co-founder and Chief Science Officer at CannaKeys 360 ̊, an online platform designed to demystify the science of the endocannabinoid system.

The Cannabis Health Index pdf by Uwe Blesching

This comprehensive sourcebook combines evidence-based insights from more than 1,000 studies from cannabinoid and consciousness research to present a convincing case for the powerful healing effects of medical marijuana on over 100 chronic symptoms and diseases. Written by a former paramedic with a PhD in alternative healthcare, this in-depth reference shows that the subtle shifts in awareness commonly observed in cannabis-using patients vastly contribute to these compounds' therapeutic potential. The Cannabis Health Index is organized into condition-specific chapters, with eye-catching ratings of cannabis efficacy for each symptom, along with recommendations for use, and sidebars that suggest related mindfulness-based practices that enhance the body's own ability to heal. Organized alphabetically from aging to wound care, with sections on a variety of conditions including infections, cancer, cardiovascular health, eye diseases, inflammatory diseases, neurological diseases, and much more, the Index reveals that the huge body of scientific studies focused on cannabis is a tremendously under-utilized repository of knowledge. In synthesizing the findings of these studies, Blesching brings clarity to the process of making informed decisions about cannabis as a valid treatment. Informative, user-friendly, and practical, The Cannabis Health Index presents striking evidence that cannabis is remarkable safe and effective when used within the proper therapeutic window, especially compared with the risks of managing chronic symptoms with pharmaceuticals